Accord Healthcare, having received final FDA approval, has launched additional strengths of Hydroxychloroquine Sulfate tablets in dosages of 100mg, 300mg and 400mg. Hydroxychloroquine is the generic version of Plaquenil and is primarily used to treat rheumatoid arthritis, lupus and malaria.   Prior to Accord’s offering of additional strengths, the only strength available was 200mg. Accord’s offering of 100mg, 300mg and 400mg will alleviate the need to break the 200mg tablet in orde...